Works from 2017
Hormonal contraception and therapy use in breast cancer survivors: Do recurrence and mortality risks increase?, Sara Stanenas, Danielle M. Greer, Jessica J F Kram, et al. (Abstract)
Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553), Susanne M Arnold, Kari Chansky, Markos Leggas, et al. (Article)
Practice model for advanced practice providers in oncology, Jamie Cairo, Mary Ann Muzi, Deanna Ficke, et al. (Article)
Predicting nonmuscle invasive bladder cancer recurrence and progression in a United States population, Kourosh Ravvaz, Marcus E Walz, John Weissert, et al. (Article)
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al. (Article)
Robustness of a Newly Proposed Risk Schema for Lymphatic Dissemination in Endometrioid Endometrial Cancer, Danielle M. Greer, Jessica J.F. Kram, Callie M. Cox Bauer, and Scott A. Kamelle (Supplement)
Robustness of a newly proposed risk schema for lymphatic dissemination of endometrioid endometrial cancer, Danielle M. Greer, Jessica J F Kram, Callie M. Cox Bauer, et al. (Poster)
The emerging role of professional social media use in oncology, Mina S Sedrak, Don S Dizon, Patricia F Anderson, et al. (Editorial)
Triathlon training for women breast cancer survivors: feasibility and initial efficacy, Alexander V Ng, Alyson N Cybulski, Ashley A Engel, et al. (Article)
Works from 2016
Abstract 2594: clinical pathways as a platform to support clinical research, Peter G. Ellis (Abstract)
Abstract 285: Disulfiram, a dual MGMT and aldehyde dehydrogenase inhibitor, sensitizes ER-positive breast cancer cells to temozolomide and cyclophosphamide, George C. Bobustuc, Deborah Donohoe, Alisher Holmuhamedov, et al. (Abstract)
Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance), WM Sikov, DA Berry, CM Perou, et al. (Abstract)
Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP), Peter G. Ellis (Abstract)
Addressing administrative and regulatory burden in cancer clinical trials: Summary of a stakeholder survey and workshop hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes, Julie M Vose, Laura A Levit, Patricia Hurley, et al. (Article)
An online tool to assess the quality of research programs, Renee Yvonne Smith, Patricia A. Hurley, Michael A. Thompson, et al. (Abstract)
A Pilot Study of Circulating Tumor Cells in Stage IV Non-Small Cell Lung Carcinoma, Max Haid, Edward Chesna, Mary Theodoroff, Debra K. Spaeth, Cheruppolil R. Santhosh-Kumar, and Zahid N. Dar (Original Research)
Bell’s palsy as the initial presentation of multiple myeloma: A case report, Qiaofang Chen, Carol Huibregtse, and Cheruppolil R. Santhosh-Kumar (Case Report)
Breast cancer diagnosed by stress SPECT sestamibi: The role of inverse gray-scale imaging, Khawaja Afzal Ammar, Armaan Shaikh, Michael Anigbogu, et al. (Article)
Challenges with research contract negotiations in community-based cancer research, Michael A. Thompson, Patricia A Hurley, Bryan Faller, et al. (Article)
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, David P Steensma, Medrdad Abedi, Rafael Bejar, et al. (Article)
Current diagnosis patterns for acute myeloid leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML disease registry, Tracy I. George, Harry P. Erba, David P. Steensma, et al. (Abstract)
Determining the Incidence and Factors of Cardiotoxicity in Breast Cancer Patients Treated With Anthracycline and/or Trastuzumab-Containing Regimen at Aurora Health Care, Stephanie Ghojallu, Matthew Rappelt, Han-Yang Chen, Ruth Perez, Lydia Garlie, Geoffrey Riddell, Yingying Gu, Jun Zhang, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)
Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells, Johnathan E Lawrence, Christopher J Steele, Richard A Rovin, et al. (Article)
Disease-specific hashtags for online communication about cancer care, Matthew S Katz, Audun Utengen, Patricia F Anderson, et al. (Article)
Effect on clinical trial participation by integration of a clinical pathway program into an electronic health record (EHR), Corey J. Shamah and Thomas J. Saphner (Abstract)
Engaging managing physicians in clinical staging prior to the initiation of cancer treatment, Anne Barry-Weers, Carol Huibregtse, Marija Bjegovich-Weidman, et al. (Abstract)
Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S. Smith, et al. (Article)
Extradigital glomus tumor: a rare etiology for wrist soft tissue mass, Justin E. Friske, Vipul Sharma, S A. Kolpin, et al. (Case Report)
Global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients: the Insight-MM Study, Robert M. Rifkin, Faith E. Davies, Antonio Palumbo, et al. (Abstract)
Implementation of treatment pathways in a large integrated health care system, James Leighton Weese, Levi Citrin, Corey J. Shamah, et al. (Abstract)
Implementing survivorship care planning in a large integrated cancer program, M. Jamie Cairo, Carol Huibregtse, Adam Ferry, et al. (Abstract)
Insights from building a new National Cancer Institute Community Oncology Research Network Program site, Thomas J. Saphner, Michael A. Thompson, Sara Planton, et al. (Article)
Integration of a clinical pathways software into an EHR in a large, multisite, hospital-affiliated community oncology setting, Corey J. Shamah, Thomas J. Saphner, Jacob C. Frick, et al. (Abstract)
Measures of appropriateness and value for breast surgeons and their patients: the american society of breast surgeons choosing wisely (®) initiative, Jeffrey Landercasper, Lisa Bailey, Tiffany S Berry, et al. (Article)
Metastatic bone disease: femur—tibia, Nicholas Webber (Book Chapter)
MGMT inhibition by disulfiram sensitizes ER+ breast cancer cells to temozolomide and cyclophosphamide, Santhi Konduri, Deborah Donohoe, Alisher Holmuhamednov, et al. (Poster)
Multiple myeloma vaccination sequential immune response pilot study, Michael A. Thompson, Martin K. Oaks, John O Richards, et al. (Abstract)
New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy, Ameya Paranjpe, Nathan I Bailey, Santhi Konduri, et al. (Article)
New primary palliative care (PC) model for community cancer clinics (CCC), Cheruppolil R. Santhosh-Kumar, Deborah Gray, Stephanie Struve, et al. (Abstract)
NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S Smith, et al. (Article)
Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis, Zeeshan Jawa, Ruth M Perez, Lydia Garlie, et al. (Article)
Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance, Pranshu Mohindra, Erich Urban, Jonathan D Pagan, et al. (Article)
Social media and internet resources for patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn), Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, et al. (Article)
Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)
Social media in cancer care: highlights, challenges & opportunities, Deanna J Attai, Mina S Sedrak, Matthew S Katz, et al. (Article)
Survivors speak: a qualitative analysis of motivational factors influencing breast cancer survivors' participation in a sprint distance triathlon, Karen M Robinson, Linda B Piacentine, Leslie J. Waltke, et al. (Article)
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study, Kari B Wisinski, Wei Xu, Amye J Tevaarwerk, et al. (Article)
The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma, Ahmed Al-Niaimi, Elizabeth L. Dickson, Cassandra Albertin, et al. (Article)
The role of surgical primary tumor extirpation in de novo stage IV breast cancer in the era of targeted treatment, Judy A. Tjoe, Danielle M. Greer, and Ahmed Dalmar (Abstract)
Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer, Callie Cox Bauer, Danielle M. Greer, Jessica J. F. Kram, et al. (Article)
Understanding Health Care Costs in a Wisconsin Acute Leukemia Population, Patricia Steinert and Ron A. Cisler (Original Research)
Works from 2015
American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al. (Article)
A Meta-Analysis of Incidence and Risk Factors of Trastuzumab-Induced Cardiotoxicity in Breast Cancer, Zeeshan Ali Jawa, Ruth M. Perez, Lydia Garlie, Maharaj Singh, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study, Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, et al. (Article)
Breast Cancer Screening: Early Detection Is Not Enough, Judy A. Tjoe (Editorial)
Does the Expression of Ki-67, p16 and COX-2 at Initial Diagnosis of Breast Atypia or Usual Ductal Hyperplasia Predict a Second Clinically Significant Event?, Judy A. Tjoe, Philippe Gascard, Jianxin Zhao, Gary F. Neitzel, Maharaj Singh, Brittany Last, James Marx, Thea Tlsty, and Sanjay Kansra (Supplement)
‘Everyone is an individual’: providing individualized treatment in oncology, Michael A. Thompson (Article)
Hepatology: Complete regression of locally advanced hepatocellular carcinoma following Sorafenib monotherapy, Shiva Kumar (Article)
Improving quality metric adherence to minimally invasive breast biopsy among surgeons within a multihospital health care system, Judy A. Tjoe, Danielle M. Greer, Sue Ihde, et al. (Article)
Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006, Stephanie E Johnson-Obaseki, Varant Labajian, Martin Corsten, et al. (Article)
Incidence of differentiated thyroid cancer in Canada by City of residence, Martin Corsten, Matthew Hearn, James Ted McDonald, et al. (Article)
In support of a patient-driven initiative and petition to lower the high price of cancer drugs, A Tefferi, H Kantarjian, S V. Rajkumar, et al. (Article)
Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts, MA Al-Haddad, T Kowalski, A Siddiqui, et al. (Article)
In Vitro Growth Suppression of Renal Carcinoma Cells by Curcumin, Santhi D. Konduri, Madhavi Latha Yadav Bangaru, Phu Thanh Do, Shenglin Chen, Jeffrey Woodliff, and Sanjay Kansra (Original Research)
In Vitro Growth Suppression of Renal Carcinoma Cells by Curcumin, Santhi Konduri, Madhavi Latha Yadav Bangaru, Phu Thanh Do, Shenglin Chen, Jeffrey Woodliff, and Sanjay Kansra (Supplement)
Mailed At-Home FIT Intervention to Increase Colorectal Screenings at Sixteenth Street Community Health Centers, Alexander V. Herrera, Brian Hilgeman, Michelle Buelow, and Melissa A. Lemke (Supplement)
MGMT inhibition suppresses survivin expression in pancreatic cancer, George C. Bobustuc, Anand Patel, Michael A. Thompson, et al. (Article)
Multimodality imaging in cardiooncology, Fausto Pizzino, Giampiero Vizzari, Rubina Qamar, et al. (Article)
PRACTC: Practice Readiness Academic Clinical Training Collaborative –– Gap Analysis to Advance Clinical Training for Nurse Practitioner Students, Jennifer Hartlaub, Mary Ann Muzi, M. Jamie Cairo, John R. Brill, James Weese, Kristin Rivera, Susan Hafemann, Ann M. Rohrer, Julia Schumacher, and Terri L. Vandenhouten (Supplement)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer, Joseph A Sparano, Robert J Gray, Della F Makower, et al. (Article)
Role of endovascular stenting in radiation-induced stenosis of lower extremity veins, Harold K Elias, M. Fuad Jan, and Suhail Allaqaband (Case Report)
Role of surgical staging and adjuvant chemotherapy in the treatment of uterine carcinosarcoma, O. Cabrera, C. Cho, Ahmed Dalmar, et al. (Abstract)
Social Media and Myeloproliferative Neoplasms (MPN)-Focus on Twitter and the Development of a Disease-specific Community: #MPNSM, Naveen Pemmaraju, Vikas Gupta, Ruben Mesa, et al. (Article)
Social Media and the practicing hematologist: Twitter 101 for the busy healthcare provider, Michael A. Thompson, Navneet S Majhail, William A Wood, et al. (Article)
Use of survivorship care plans to improve cost effective care following adjuvant treatment for breast cancer: e#42, Jean Rosiak (Abstract)
Using social media to learn and communicate: it is not about the tweet, Michael A. Thompson (Article)
What Are the Recommended Timing and Screening Modalities for Women at Higher Risk of Developing Breast Cancer? A Clin-IQ, Summer Jatala, Shawn Fitzgerald, Pamela Tietze, Kalyanakrishnan Ramakrisnan, Laine H. McCarthy, and Elizabeth Wickersham (Topic Synopsis)
Works from 2014
An analysis of cancer-specific Twitter conversations among physicians in 2013, Brian Bowers Reid, Kayla Nicole Rodriguez, Michael A. Thompson, et al. (Abstract)
An Overview of Cancer Rehabilitation and Exercise in the Literature: Promoting Increased Referrals to Improve Oncology Outcomes, Leslie J. Waltke (Review)
An Uncommon Presentation for Cardiac Melanoma, Burcu Gul, Michael N. Young, David A. Slosky, Mark A. Lawson, and Jeffrey N. Rottman (Review)
A Rendezvous with an Unexpected Diagnosis, Helen C. Williams and Alexandria Rogers (From the Other Side of the Table)
Assessing Technologies for Information-Seeking on Prostate Cancer Screening by Low-Income Men, Susan W. McRoy, Emily M. Cramer, and Hayeon Song (Original Research)
A standardized approach for managing chemotherapy-induced rash, Laura E. Poggi, Jennifer Godden, and Sol Yoder (Poster)
Autoantibodies to the NY-ESO-1 Tumor Antigen in Metastatic Melanoma: Sialylation of the Fc Region of Immunoglobulin G Induces Differential Expression Signatures of Inflammatory Molecules During Dendritic Cell Differentiation and Maturation, Martin Oaks, Nathaniel Rein, John O. Richards, and James Shaffer (Original Research)
Bone mineral density screening should be routine in lymphoma patients, Michael A. Thompson, Jason R. Westin, and Frederick B. Hagemeister (Letter)
Breast atypia: timing of progression to subsequent clinically significant event, Judy A. Tjoe, Maharaj Singh, Brittany S. Last, et al. (Abstract)
Cardio-Oncology: Success Breeds New Challenges, Opportunities, Charles A. Bomzer and Bijoy K. Khandheria (Editorial)
Cardiovascular Toxicity of Common Chemotherapy Drugs Used to Treat Breast Cancer: An Overview, Charles A. Bomzer (Review)
Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry, David P. Steensma, Mehrdad Abedi, Eyal C. Attar, et al. (Abstract)
Current surgical treatment strategies for hepatocellular carcinoma in North America, Adeel S Khan, Kathryn J Fowler, and William C Chapman (Article)
Diagnosis of Chemotherapy-Induced Cardiotoxicity, Fausto Pizzino, Giampiero Vizzari, Charles A. Bomzer, Rubina Qamar, Scipione Carerj, Concetta Zito, and Bijoy K. Khandheria (Review)
Does expression of estrogen receptor, progesterone receptor, and HER2 in atypical breast lesions predict a subsequent clinically significant event?, Judy A. Tjoe, Gary F. Neitzl, Maharaj Singh, et al. (Poster)
Expression pattern of estrogen, progesterone and HER2/neu receptors in atypical breast lesions does not predict subsequent clinically significant event, Judy A. Tjoe, Gary F. Neitzl, Maharaj Singh, et al. (Abstract)
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study, Mark E Burkard, Kari B Wisinski, Uchenna O Njiaju, et al. (Article)
Getting quality data back to frontline providers, Anne Barry-Weers, Carol Huibregtse, Sue Ihde, et al. (Poster)
Implementation of pharmacy services in 22 oncology clinics, Ashley Feldt and Jennifer Godden (Poster)
Improving oncology patients' perception of pain management in the inpatient setting using a multidisciplinary approach, Jayme Cotter (Abstract)
Interventions to optimize the use of colony-stimulating factors, Heena Rathod and Sol Yoder (Poster)